This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Beijing Immunochina Pharmaceuticals Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yanping Ding - Innovator in Chimeric Antigen Receptor Optimization
Introduction
Yanping Ding is a prominent inventor based in Beijing, China. She has made significant contributions to the field of immunology, particularly in the optimization of chimeric antigen receptors. Her work is crucial for advancing therapeutic strategies in cancer treatment.
Latest Patents
Yanping Ding holds a patent titled "Optimization of Chimeric Antigen Receptor." This patent represents her innovative approach to enhancing the efficacy of immunotherapies. It showcases her commitment to improving patient outcomes through scientific research.
Career Highlights
Yanping Ding is affiliated with Beijing Immunochina Pharmaceuticals Co., Ltd. Her role in the company allows her to apply her expertise in developing cutting-edge therapies. She has been instrumental in driving research initiatives that focus on novel treatment options.
Collaborations
Yanping collaborates with talented professionals in her field, including Feifei Qi and Xinan Lu. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Yanping Ding's contributions to the field of immunology and her patent on chimeric antigen receptor optimization highlight her as a key figure in advancing cancer therapies. Her work continues to inspire future innovations in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile